G1 Therapeutics, Inc. is a commercial-stage biopharmaceutical company focused on the discovery, development and delivery of next generation therapies that improve the lives of those affected by cancer, including the Company’s first commercial product, COSELA™ (Trilaciclib).

Biotechnology

G1 Therapeutics

G1 Therapeutics' headquarters in NC, United States

Shannon Lim

Zaida Padron

Raj Malik

Darlene Burns

Olu O. Oyeneye

Monica Thomas

Mike Townsend

Bobirjon Mukamilov

Maggie Gagnon

Genevieve Black

Glenn P. Muir

Jacks Lee

Norman E. Sharpless

Description